Characterizing Human Exceptional Longevity
Characterizing Human Exceptional Longevity
批准号:
8143141
负责人:
THOMAS T PERLS
金额:
$3.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2012-01-31
关键词:
Activities of Daily LivingAgeAgingAmericanAwardBehavioral GeneticsBioethicsCardiovascular DiseasesCardiovascular systemCentenarianClinicalClinical InvestigatorClinical ResearchClinical TrialsCollectionCommunitiesDataDiabetes MellitusDiseaseEducationEnrollmentEnsureEpidemiologic StudiesEpigenetic ProcessFacultyFamilyFamily StudyFamily memberFundingFutureGenerationsGeneticGenetic MaterialsGeriatricsGoalsGrantHandHealthHumanIndividualK-Series Research Career ProgramsLifeLipidsLongevityMedical StudentsMentorsMentorshipMolecular GeneticsNew EnglandNuclear FamilyPaperPatternPersonalityPhenotypePhysiciansPrevalenceProbabilityProtocols documentationPublic HealthPublishingQualifyingRecruitment ActivityRecurrenceReligionResearchResearch PersonnelResourcesRiskSchoolsScientistSiblingsSiteSpiritualityStagingStrokeStudentsSurvivorsTraining ProgramsTranslatingUnited States National Institutes of Healthage relatedbasecareercareer developmentcohortcopingdisabilityend of lifeexperiencegenetic associationgenetic epidemiologygenetic linkagegenetic pedigreememberoffspringpatient oriented researchpopulation basedpre-doctoralprofessorrepositorysegregationtransmission process
中文摘要
这是一份修订后的以患者为中心的研究生涯中期研究人员奖(K24)的申请书。这个
申请者Thomas Perls博士是医学和老年病学副教授,创始人兼董事
新英格兰百岁老人研究的。曾获得NIH内科科学家奖(K-12)和Paul
比森衰老研究学院学者奖,珀尔斯博士继续成为一名独立科学家
致力于以病人为中心的研究。具体地说,通过这些早期的指导性奖项,珀尔斯博士
在对一个非常老的队列进行基于人群的表型研究方面拥有丰富的专业知识。他的
他收到了另外四笔NIH补助金(RO-3、R-21和两笔R0-1),证明了他的独立性。珀尔斯博士
在指导学生和临床研究人员职业生涯的不同阶段方面有着丰富的记录。
他曾指导过五位美国老龄研究联合会医学生老年医学学者,三位
医科预科生和研究生,两名老年学研究员,一名博士前研究员和一名助理
老年病学教授。所有这些学员都成功地与Perls博士一起发表了论文。在执行任务时
他的研究由R01资助,这是一项基于人口的生物人口学研究,针对百岁老人和他们的
家庭,这项K24拨款规定,15%的努力将用于收集初步数据和开发
申请资助一项百岁老人的遗传流行病学研究。珀尔斯博士将参加
生物伦理学、负责任的临床调查和遗传流行病学是他职业生涯的一部分
与发展相关的教育目标。这些百岁老人研究为受训者提供了肥沃的土壤
有临床研究方面的实践经验。超凡长寿的无数方面可以用来
从灵性、个性、适应能力和功能储备到人口学和临床的研究
对表观遗传关联的观察。35%的努力将致力于指导已建立的和未来的
指导者。一个具有广泛培训计划的庞大和多样化的学术社区将确保
一大批高素质和有才华的学员。
与公共健康相关:在珀尔斯博士的指导下,对人类异常长寿的研究提供了
学员,从学生到初级教员,为学习成功的广泛方面提供了肥沃的土壤
从宗教、个性、适应能力和功能储备到环境、行为和
基因与特殊生存的联系。随后的发现可能最终会转化为战略
帮助人们更成功地变老。
英文摘要
This is a revised application for a Mid-Career Investigator Award in Patient-Oriented Research (K24). The
applicant, Dr. Thomas Perls, is an Associate Professor of Medicine and Geriatrics and Founder and Director
of the New England Centenarian Study. Having received an NIH physician scientist award (K-12) and a Paul
Beeson Faculty Scholar in Aging Research Award, Dr. Perls proceeded to become an independent scientist
devoted to patient-oriented research. Specifically, through these earlier mentored awards, Dr. Perls
developed expertise in conducting a population-based phenotypic study of an extremely old cohort. His
independence is demonstrated by his receipt of four other NIH grants (RO-3, R-21 and two R0-1s). Dr. Perls
has a substantial record of mentoring students and clinical investigators at various stages of their careers.
He has mentored five American Federation of Aging Research Medical Student Geriatrics Scholars, three
premedical and pre-graduate school students, two geriatrics fellows, a pre-doctoral fellow and an Assistant
Professor in Geriatrics. All of these trainees successfully published papers with Dr. Perls. While carrying out
the aims of his R01-funded study, a population-based bio-demographic study of centenarians and their
families, this K24 grant provides that 15% effort will be devoted to gathering preliminary data and developing
applications to fund a genetic epidemiological study of centenarians. Dr. Perls will attend courses in
bioethics, responsible conduct of clinical investigations and genetic epidemiology as a part of his career
development-related education goals. These centenarian studies provide fertile ground for mentees to gain
hands-on experience in clinical research. Innumerable aspects of exceptional longevity are available for
study from spirituality, personality, adaptive capacity and functional reserve, to demographic and clinical
observations to epigenetic associations. 35% effort will be dedicated to mentoring established and future
mentees. A large and diverse academic community with a broad spectrum of training programs will ensure
an ample pool of highly qualified and talented mentees.
Relevance to public health: The study of human exceptional longevity under Dr. Perls's mentorship, provides
trainees, from students to junior faculty, fertile ground for studying a broad range of aspects of successful
aging from religion, personality, adaptive capacity and functional reserve to environmental, behavioral and
genetic associations with exceptional survival. Subsequent findings may ultimately translate into strategies
that help people age more successfully.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Typologies of extreme longevity myths.
极端长寿神话的类型。
DOI:
10.1155/2010/423087
发表时间:
2010
期刊:
Current gerontology and geriatrics research
影响因子:
--
作者:
[Young,RobertD, Desjardins,Bertrand, McLaughlin,Kirsten, Poulain,Michel, Perls,ThomasT]
通讯作者:
Perls,ThomasT
Hope drives antiaging hype.
希望推动抗衰老炒作。
DOI:
10.3949/ccjm.73.12.1039
发表时间:
2006
期刊:
Cleveland Clinic journal of medicine
影响因子:
6.1
作者:
[Perls,ThomasT]
通讯作者:
Perls,ThomasT
Administrative Core
-
批准号:10276390
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2021
-
负责人:THOMAS T PERLS
-
依托单位:
Administrative Core
-
批准号:10689331
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2021
-
负责人:THOMAS T PERLS
-
依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
-
批准号:10017131
-
项目类别:
-
资助金额:$430.23万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
-
批准号:10678171
-
项目类别:
-
资助金额:$499.8万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
-
批准号:10449626
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Phenotyping Core
-
批准号:10388280
-
项目类别:
-
资助金额:$683.97万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Phenotyping Core
-
批准号:10616715
-
项目类别:
-
资助金额:$213.45万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Protein Signatures of APOE2 and Cognitive Aging
-
批准号:10451539
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2018
-
负责人:THOMAS T PERLS
-
依托单位:
Protein Signatures of APOE2 and Cognitive Aging
-
批准号:10219143
-
项目类别:
-
资助金额:$64.14万
-
财政年份:2018
-
负责人:THOMAS T PERLS
-
依托单位:
Protein Signatures of APOE2 and Cognitive Aging
-
批准号:10408304
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2018
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7913647
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2009
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7030623
-
项目类别:
-
资助金额:$13.29万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7189048
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7370992
-
项目类别:
-
资助金额:$13.51万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7572824
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
The Long Life Family Study
-
批准号:8144308
-
项目类别:
-
资助金额:$75.73万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
Exceptional survival and longevity in New England
-
批准号:7126256
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
Exceptional survival and longevity in New England
-
批准号:6943503
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
Long Life Family Study: Boston Field Center
-
批准号:8695587
-
项目类别:
-
资助金额:$129.52万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
The Long Life Family Study
-
批准号:8319402
-
项目类别:
-
资助金额:$75.39万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: